open access
Aortic dissection four months after SARS-CoV-2 infection in a patient with Fabry disease whose targeted treatment was stopped 2 months earlier
Affiliations- Department of Cardiology, WKK Westküstenkliniken Heide und Brunsbüttel, Heide, Germany
- Department of Coronary Artery Disease and Cardiac Rehabilitation, National Institute of Cardiology, Warszawa, Poland
open access
Abstract
Abstract
About this articleTitle
Aortic dissection four months after SARS-CoV-2 infection in a patient with Fabry disease whose targeted treatment was stopped 2 months earlier
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Clinical vignette
Pages
713-714
Published online
2022-05-20
Page views
498
Article views/downloads
111
DOI
10.33963/KP.a2022.0133
Pubmed
Bibliographic record
Kardiol Pol 2022;80(6):713-714.
Authors
Marcin Kamil Dobrowolski
Magdalena Marczak
Rafał Dąbrowski
References (3)- Germain DP. Fabry disease. Orphanet J Rare Dis. 2010; 5: 30.
- Nowicki M, Bazan-Socha S, Błażejewska-Hyzorek B, et al. Enzyme replacement therapy in Fabry disease in Poland: a position statement. Pol Arch Intern Med. 2020; 130(1): 91–97.
- Dostálová G, Hulkova H, Linhart A. Anderson-Fabry disease: No histological signs of pathological accumulation in arterial and venous endothelium during pegunigalsidase alfa therapy. Kardiol Pol. 2021; 79(12): 1385–1386.
